David-Alexandre C. Gros - Aug 17, 2021 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role: Chief Executive Officer, Director
Signature: /s/ David-Alexandre Gros
Stock symbol: ELDN
Transactions as of: Aug 17, 2021
Transactions value $: $24,840
Form type: 4
Date filed: 8/19/2021, 04:05 PM
Previous filing: Jun 10, 2021
Next filing: Dec 21, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELDN	Common Stock	Purchase	$24.8K	+4K	+133.33%	$6.21	7K	Aug 17, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were purchased in multiple open market transactions in accordance with the Issuer's trading policies at prices ranging from $6.20 to $6.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were purchased in multiple open market transactions in accordance with the Issuer's trading policies at prices ranging from $6.20 to $6.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.